Hoelen DW, Tjan DH, Schouten MA, Dujardin BC, van Zanten AR. Severe Yersiniaenterocolitica sepsis after blood transfusion. Neth J Med 2007; 65(8): 301-4.
Jacobs J, Jamaer D, Vandeven J, Wouters M, Vermylen C, Vandepitte J. Yersiniaerocolitica in donor blood: a case report and review. J Clin Microbial 1989; 27(5): 1119-21.
Hoogkamp-Korstanje JA, de Koning J, Heesemann J. Persistence of Yersiniaenterocolitica in man. Infection 1988; 16(2): 81-5.
Kendrick CJ, Baker B, Moris AJ, O’Toole PW. Identification of Yersinia-infected donors by anti-Yop IgA immunoassay. Transfusion 2001; 41(11): 1365-72.
Hanski C, Naumann M, Grützkau A, Pluschke G, Friedrich B, Hahn H, et al. Humoral and cellular defense against intestinal murine infection with Yersiniaenterocolitica. Infect Immun 1991; 59(3): 1106-11.
Aleksic S, Burwitz K, Bockemühl J, Aleksić V. Immune response to flagellar antigens in human infections with Yersiniaenterocolitica. Contrib Microbiol Immunol 1991; 12: 110-6.
High frequency of Yersinia antibodies in healthy populations in Finland and Germany. Rheumatol Int 1997; 16(6): 227-9.
Cornelis GR, Boland A, Boyd AP, Geuijen C, Iriarte M, Neyt C, et al. The virulence plasmid of Yersinia, an antihost genome. Microbiol Mol Biol Rev 1998; 62(4): 1315-52.
Gibb AP, Martin KM, Davidson GA, Walker B, Murphy WG. Modeling the growth of Yersiniaenterocolitica in donated blood. Transfusion 1994; 34(4): 304-19.
Tomas H, Mooseder G, Al Dahouk S, Bartling C, Scholz HC, Strauss R, et al. Seroprevelence of anti-Yersinia antibodies in healthy Austrians. Eur J Epidemiol 2006; 21(1): 77-81.
Prentice M. Transfusion yersiniaenterocolitica. BMJ 1992; 305(6855): 663-4.
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran 2Tehran Regional Educational Blood Transfusion Center, Tehran, Iran
Abstract Background and Objectives
The recomwell Yesinia uses YOPs (Yesinia outer membrane proteins) produced by recombinant techniques that are highly specific for the genus Yersinia. The aim of this study is to determine the prevalence of Yesinia Yop-specific IgA antibodies in 492 healthy blood donors and make comparison between seropositivity and the presence of y.enterocolitica infection in blood donors.
Materials and Methods
In the descriptive study, sera from 492 healthy Iranian blood donors were studied for Yesinia Yop-specific IgA antibodies by two different techniques, enzyme immunoassay (EIA) and western blot to determine the prevalence of Yersinia antibody. Secondly, we cultured the whole blood of Yesinia seropositive donors which has been stored in 1-6◦ C for 35 days. Thirdly, we compared the rate of seropositivity with the results of donors’ blood cultures.
Results
The prevalence rates of Yesinia Yop-specific IgA antibodies in Tehran healthy blood donors were 12.5% and 8.5% by EIA and Western Blot, respectively. The blood cultures of all seropositive donors were negative.
Conclusions
Although the prevalence rate of Yesinia Yop-specific IgA antibodies in Iranian healthy blood donors was high there was no correlation whatsoever between seropositivity and donors’ bacteremia.
Correspondence: Timori Naghadeh H., Pathologist. Assistant Professor of Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine.
P.O.Box: 1157-14665, Tehran, Iran. Tel: (+9821) 88601564; Fax: (+9821) 88060717
E-mail: timori13@gmail.com
Timori Naghadeh H, Dabir Moghaddam A, Pirmohammad Jamaat Z, Sharifi R. The Prevalence of Yersinia Yop-specific IgA antibodies in Iranian blood donors evaluated by specific serology and blood culture methods. Sci J Iran Blood Transfus Organ 2015; 12 (2) :173-178 URL: http://bloodjournal.ir/article-1-867-en.html